Evidence of a prothrombotic state in early stages of chronic Chagas’ disease

Ramón Nicasio Herrera; Sofía Graciela Berman; Héctor Lucas Luciardi

2004, Number 4

Next >>

Arch Cardiol Mex 2004; 74 (4)

Evidence of a prothrombotic state in early stages of chronic Chagas’ disease

Herrera RN, Berman SG, Luciardi HL

Full text

How to cite this article

Language: Spanish
References: 27
Page: 259-261
PDF size: 45.42 Kb.

Text Extraction

No abstract

REFERENCES

Espinosa R, Carrasco H, Belandria F, Fuenmayor A, Molina C, Martínez O: Life expectancy analysis in patients with Chagas’ disease: prognosis after one decade (1973-1983). Intern J Cardiol 1985; 8(1): 45-56.
Hagar JM, Rahimtoola SH: Chagas’ Heart Disease. Curr Probl Cardiol 1995; 20(12): 825-924.
Storino R: El tratamiento antiparasitario de la enfermedad de Chagas. ¿Debe darse a todos? Rev Argent Cardiol 2002; 70: 391-398.
Carrasco GH, Palacios-Prü E, Dagert de Scorza C, Molina C, Inglessis G, Mendoza R: Clinical, histochemical, and ultrastructural correlation in septal endomyocardial biopsies from chronic chagasic patients: detection of early myocardial damage. Am Heart J 1987; 113: 716-724.
Laguens R, Cabeza MP, Vigliano C: Patogenia de la miocarditis chagásica crónica. Medicina (Buenos Aires) 1999; 59(Suppl II): 63-68.
Bhayana V, Henderson A: Biochemical markers of myocardial damage. Clin Biochem 1995; 28: 1-19.
Basquiera A, Capra R, Omelianiuk M, Amuchástegui M, Madoery R, Salomone O: Concentraciones séricas de troponina T en pacientes con enfermedad de Chagas crónica. Rev Esp Cardiol 2003; 56(7): 742-744.
Oliveira J, Correa de Araujo R, Navarro M, Muccillo G: Cardiac thrombosis and thromboembolism in chronic Chagas’ heart disease. Am J Cardiol 1983; 52: 147-151.
Arteaga FE, Pereira BAC, Ianni BM, Mady C, Lopes EA, Brito VC, et al: Trombose cardiaca e embolia em pacientes fallecidos de cardiopatía chagásica crónica. Arq Bras Cardiol 1989; 52(4): 189-192.
Carrasco GH, Avilan L, Barboza J, Fuenmayor A, Dávila D, Pérez T: Enfermedad tromboembólica pulmonar y de los miembros inferiores en los pacientes con insuficiencia cardíaca congestiva global crónica. Arch Inst Cardiol Mex 1978; 48(1): 214-232.
Braga J, Labrunie A, Villaca F, do Nascimento E, Quijada L: Tromboembolism in chronic Chagas’ heart disease. Rev Paul Med 1995; 113(2): 862-66.
Roldan SV, Marin OF, Pineda RJ, Climente PV, Martinez J, Vera PM, et al: Thrombogenic and endotelial damage markers in patients with ischemic systolic impairment. Rev Esp Cardiol 2001; 54(10): 1155-60.
Lip G, Gibbs C: Does heart failure confer a hypercoagulable state? Virchow’s triad revisited. J Am Coll Cardiol 1999; 33(5): 1424-26.
Rouvier J, Scazziota A: Factores y Marcadores de Riesgo de Trombosis. Capítulo 3. Cuadernos de Trombosis. Infomed. Tomo I 1999; 39-40.
Herrera R, Diaz E, Perez R, Chain S, Sant-Yacumo R, Rodríguez E, et al: Estado protrombótico en estadíos tempranos de la enfermedad de Chagas crónica. Rev Esp Cardiol 2003; 56(4): 377-382.
Britto C, Cardoso M, Vanni C, Hasslocher-Moreno A, Xavier S, Oelemann W, et al: Polimerase chain reaction on detection of Trypanosoma cruzy in human blood samples as a tool for diagnosis and treatment evaluation. Parasitology 1995; 110: 241-247.
Tarleton R: Parasite persistence in the etiology of Chagas’ disease. Int J Parasitol 2001; 31: 550-554.
Salomone O: Miocardiopatía chagásica y trombosis: el principio y el final de una relación peligrosa. Rev Esp Cardiol 2003; 56(4): 333-334.
Shebuski R, Kilgore K: Role of inflammation mediators in thrombogenesis. Pharmacol Exp Ther 2002; 300: 729-735.
Blahe G, Ridker P: Novel clinical markers of vascular wall inflammation. Circulation Res 2001; 89: 765-771.
Blankeberg S, Rupprecht H, Poirier O, Bickel C, Smieja M, Hafner G, et al: AtheroGene Investigators: Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 2003; 107: 1579-1585.
Datta J, Ewenstein B: Regulated secretion in endothelial cells. Biology and clinical implications. Thromb Haemost 2001; 86: 1148-1155.
Young J, Libby P: Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost 2002; 88: 554-567.
Salomone O, Caeiro T, Madoery R, Amuschategui M, Omelinauk M, Juri D, Kaski J: High plasma immunoreactive endothelin levels in patients with Chagas’ cardiomyopathy. Am J Cardiol 2001; 87(10): 1217-1220.
Salomone O, Juri D, Omelianiuk M, Sembaj A, Aguerri A, Carriazo C, et al: Prevalence of circulating Trypanosoma cruzi detected by polymerase chain reaction in patients with Chagas’ cardiomyopathy. Am J Cardiol 2000; 85(10): 1274-1276.
Espinosa R, Carrasco H, Belandria F, Fuenmayor A, Molina C, Gonzalez R, et al: Life expectancy analysis in patients with Chagas’ disease: prognosis after one decade (1973-1983). Intern J Cardiol 1985; 8: 45-56.
Rosemberg R, Aird W: Vascular bed-specific hemostasis and hypercoagulable states. N Engl J Med 1999; 340(20): 1555-1564.